Document:

Unassociated Document

    THIS NOTE AND THE SECURITIES ISSUABLE
UPON THE CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
1933, AS AMENDED.  THEY MAY NOT BE SOLD,
OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE
REGISTRATION STATEMENT AS TO THE SECURITIES UNDER SAID ACT OR AN OPINION OF
COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT
REQUIRED.

     

     

    CNS
RESPONSE, INC.

    SENIOR
SECURED CONVERTIBLE PROMISSORY NOTE

    
      	
              $250,000.00

            	 
      	 
      	
              March
      30, 2009

            
	 
      	 
      	 
      	
              Costa Mesa,
      California

            

    

    

    FOR VALUE
RECEIVED, CNS Response, Inc., a Delaware corporation (the “Company”), promises to pay to
SAIL Venture Partners, LP (“Investor”), or its registered
assigns, in lawful money of the United States of America, the principal sum of
Two Hundred Fifty Thousand Dollars ($250,000.00), together with interest from the date of
this Note on the unpaid principal balance at a rate equal to 8.0% per annum,
computed on the basis of the actual number of days elapsed and a year of 365
days.  All unpaid principal, together with any then unpaid and accrued
interest and other amounts payable hereunder, shall be due and payable,
unless converted pursuant
to Section 7 below, on the
earlier of (i) a
declaration by Investor on or after June 30, 2009 (the “Maturity
Date”) that such amounts
are due and payable or (ii) when, upon or after the
occurrence of an Event of Default (as defined below), such amounts are made due and payable in accordance with the terms
hereof.  This Note is one of two “Notes” in the form hereof issued by the
Company on or about the date hereof (this Note, together with such other
Note, the “Notes”).   This Note is secured by a lien on all
of the assets of the Company pursuant to the terms of Section 6
below.

     

    The
following is a statement of the rights of Investor and the conditions to which
this Note is subject, and to which the Company and Investor agree:

     

    1. Definitions.  As
used in this Note, the following capitalized terms have the following
meanings:

     

    (a)
“Company” includes the
corporation initially executing this Note and any Person which shall succeed to
or assume the obligations of the Company under this Note.

     

    (b)
“Equity Financing Conversion
Price” shall mean 90% of the per share price paid for the securities in
the Qualified Equity Financing.

     

    (c)
“Investor” shall mean
the Person specified in the introductory paragraph of this Note or any Person
who is the registered holder of this Note, and “Investors” shall mean the
Persons who are the registered holders of the Notes.

     

    (d)  “Outstanding Debt” shall mean,
as of a particular time, the then outstanding principal amount of this Note and
all then accrued and unpaid interest thereon.

     

    (e)
“Person” shall mean and
include an individual, a partnership, a corporation (including a business
trust), a joint stock company, a limited liability company, an unincorporated
association, a joint venture or other entity or a governmental
authority.

     

    (f)
“Securities Act” shall
mean the Securities Act of 1933, as amended.

     

    2. Interest.  Subject
to Sections 3 and 7, accrued interest on this Note shall be payable on the earlier of (i) a declaration by Investor on or after
the Maturity Date that the Outstanding Debt is due and payable and (ii) when, upon or after the
occurrence of an Event of Default (as defined below), the Outstanding Debt is
made due and payable in accordance with the terms
hereof.  For the sake of clarity, this Note shall remain
outstanding in the event that the registered holder of the other Note issued on
or around the date hereof makes the declaration set forth in clause (i) of this
Section 2 with respect to such other Note and the Investor does not make such a
declaration with respect to this Note.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    3. Prepayment.  This
Note may not be prepaid except with the prior written consent of the Investors
holding outstanding Notes.  Notwithstanding any other provision of
this Note, if prior to the date on which all of the Outstanding Debt is repaid
there is a liquidation, dissolution or winding-up of the Company (a “Liquidation Event”), then,
unless Investor provides written notice to the Company to the contrary prior to
the Liquidation Event, concurrently with the Liquidation Event, in full
satisfaction of the Outstanding Debt, the Company shall pay Investor an amount
equal to the product of (x) 250% multiplied by (y) the Outstanding
Debt.  Investor agrees to deliver the original of this Note (or a
notice to the effect that the original Note has been lost, stolen or destroyed
along with an indemnity with respect thereto in a form satisfactory to the
Company) at the closing of the Liquidation Event for cancellation; provided, however, that upon
payment of the amounts set forth above with respect to the Outstanding Debt, the
Outstanding Debt shall be deemed satisfied and paid in full and the Company
shall have no other obligation with respect to the Outstanding Debt, whether or
not this Note is delivered for cancellation as set forth in the preceding
sentence.

     

    4. Notice of
Defaults. The Company shall furnish to Investor written notice of the
occurrence of any Event of Default hereunder promptly following the occurrence
thereof.

     

    5. Events of
Default.

     

    (a) The
occurrence of any of the following shall constitute an “Event of
Default”:

     

    (i)
Failure of the Company to pay the principal or interest on either Note when
due.

     

    (ii)
Failure of the Company to perform or observe any covenant or agreement as
required by either Note and continuation of such failure for a period of ten
(10) days following written notice from the Investors.

     

    (iii) The
Company makes a general assignment for the benefit of creditors.

     

    (iv) Any
proceeding is instituted by or against the Company seeking to adjudicate it
bankrupt or insolvent, and such proceeding is not dismissed within sixty (60)
days.

     

    (v) The
entry against the Company of a final judgment, decree or order for the payment
of money in the excess of $25,000 and the continuance of such judgment, decree
or order unsatisfied for a period of thirty (30) days without a stay of
execution.

     

    (vi) Any
representation or warranty of the Company made in this Note is proven not to
have been true and correct in any material respect as of the date of this
Note.

     

    (vii)
Leonard Brandt voluntarily or involuntarily terminates his employment with the
Company.

     

    (b) If an
Event of Default occurs and is continuing, the Investors may exercise any or all
of the following rights and remedies:

     

    (i)
Declare the Note and all interest thereon to be immediately due and payable, and
upon such declaration, the Note and all interest thereon shall immediately be
due and payable, without presentment, demand, protest or any notice of any kind,
all of which are expressly waived.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (ii)
Exercise any and all other rights and remedies available to the Investors under
Section 6 below and otherwise available to creditors at law and in
equity.

     

    6. Security
Agreement.

     

    (a) Grant of Senior Security
Interest.

     

    (i) The
Company, in consideration of the indebtedness described in this Note, hereby
grants and conveys to both Investors a security interest in and to all of the
Company’s existing and future right, title and interest in, to and under the
Collateral as defined in Section 6(b) of this Note.  The respective
rights of each of the two Investors in respect of the Collateral shall remain on
a parity with one another without preference, priority or distinction during all
times when both Notes are outstanding.

     

    (ii) The
Investors and Company agree that the indebtedness evidenced by the Notes is
senior in right of payment to all presently existing and hereafter arising
indebtedness for borrowed money of the Company, and any other indebtedness of
the Company.  All liens and security interests at any time granted by
the Company to secure the Notes, including the Collateral, are senior to all
presently existing and hereafter arising liens and security interests in the
assets of the Collateral which secure any and all other
indebtedness.  The Company has taken, and will take, all actions
necessary to make the statements in this Section 6(a)(ii) true.

     

    (b) Property.  The
property subject to the security interest (the “Collateral”) is as
follows:

     

    (i) Equipment and
Fixtures.  All equipment of every type and description owned by
the Company, including (without limitation) all present and future machinery,
furniture, fixtures, manufacturing equipment, shop equipment, office and
recordkeeping equipment, parts, tools, supplies and other goods (except
inventory) used or bought for use by the Company for any business or enterprise
and including all goods that are or may be attached or affixed to or otherwise
become fixtures upon any real property.

     

    (ii)
Accounts Receivable
and Other Intangibles.  All of the Company’s accounts, chattel
paper, contract rights, commissions, warehouse receipts, bills of lading,
delivery orders, drafts, acceptances, notes, securities and other instruments;
documents; general intangibles, patents and trademarks, applications for patents
and trademarks including, but  not limited to, the patent application
entitled “Method for Classifying and Treating Physiologic Brain Imbalances Using
Quantitative EEG,” know-how, proprietary information, all software source and
object code whether created or licensed by the Company, all data that comprises
the QEEG patient database, all forms of receivables, and all guaranties and
securities therefore.

     

    (iii)
Inventory and Other
Tangible Personal Property.  All of the Company’s inventory,
including all goods, merchandise, materials, raw materials, work in progress,
finished goods, now owned or hereinafter acquired and held for sale or lease or
furnished or to be furnished under contracts or service agreements or to be used
or consumed in the Company’s business and all other tangible personal property
of the Company.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (iv)
After-Acquired
Property.  All property of the types described in Sections
6(b)(i)-(iii), or similar thereto, that at any time hereafter may be acquired by
Company including, but not limited to, all accessions, parts, additions and
replacements.

     

    (v) Products and
Proceeds.  All products and proceeds of the Collateral from the
sale or other disposition of any of the Collateral described or referred to in
6(b)(i)-(iv), including (without limitation) all accounts, instruments, chattel
paper or other rights to payment, money, insurance proceeds and all refunds of
insurance premiums due or to become due under all insurance policies covering
the forgoing property.

     

    Notwithstanding the foregoing, the
security interest granted herein shall not extend to and the term “Collateral”
shall not include any contract right or licenses to the extent that any such
contract or license prohibits the granting of a security interest therein, and
the granting of a security interest in such contract or license would cause the
Company to be in breach thereof or otherwise lose its rights
thereunder.

     

    (c) Removal of Collateral
Prohibited.  The Company shall not permanently remove the
Collateral from its premises without the written consent of both Investors,
except that the Company may dispose of Collateral in the ordinary course of
business.

     

    (d) Protection of Security
Interest.  If an Event of Default has occurred and is
continuing, or if any action or proceeding is commenced which materially
adversely affects the Collateral or title hereto or the senior right of payment
or other interest of the Investors, then the Investors may make such appearance,
disburse such sums and take such action as they deem necessary to protect their
interest, including but not limited to: (a) disbursement of reasonable
attorney’s fees; (b) entry upon the Company’s property to make repairs to the
Collateral; and (c) procurement of satisfactory insurance that is reasonable
under the circumstances; provided, however, the Investors may undertake the
foregoing only if they have first provided written notice of the Event of
Default to the Company, and the Company has failed to cure such Event of Default
within ten (10) days of receipt of such notice.  Any amounts disbursed
by the Investors pursuant to this Section 6(d), with interest thereon, shall
become additional indebtedness of the Company secured by this Section
6.  Unless the Company and the Investors agree to other terms of
payment, such amounts shall be immediately due and payable, and if the Investors
notify the Company within five (5) days of such disbursement, all such amounts
shall bear interest from the date which is ten (10) days following the date of
disbursement at the rate stated in the Notes.

     

    (e) Forbearance by Investors Not a
Waiver.  Any forbearance by the Investors in exercising any
right or remedy hereunder, or otherwise afforded by applicable law, shall not by
a waiver of or preclude the exercise of, any right or remedy.  The
acceptance by the Investors of payment of any sum secured by this Note after the
due date of such payment shall not be a waiver of the right of either Investor
to either require prompt payment when due of all other sums so secured or to
declare a default for failure to make prompt payment.  No action taken
by the Investors shall waive the right of either Investor to accelerate the
indebtedness secured by this Section 6 and seek such other remedies as are
provided by the Notes and/or applicable law.

     

    (f) Uniform Commercial Code Security
Agreement.  This Section 6 is intended to be a security
agreement pursuant to the Uniform Commercial Code for any of the items specified
above as part of the Collateral which, under applicable law, may be subject to a
security interest pursuant to the Uniform Commercial Code of Delaware,
California or any applicable jurisdiction where the Collateral may be located
(the “UCC”), and the
Company hereby grants both Investors a security interest in said
items.  The Company agrees that the Investors may file any appropriate
document in the appropriate jurisdiction as a financing statement for any of the
Collateral.  In addition, the Company agrees to execute and deliver to
the Investors, upon their request, any financing statements, as well as
extensions, renewals and amendments thereof, and reproductions of this Note in
such form as the Investors may require to perfect a security interest with
respect to the Collateral.  The Company shall pay all costs of filing
such financing statements and any extensions, renewal, amendments and releases
thereof, and shall pay all reasonable costs and expenses of any record searches
for financing statements the Investors may reasonably require.  Upon
the occurrence and during the continuance of an Event of Default, each Investor
shall have the remedies of a secured party under the UCC and may exercise all
rights and remedies available under the UCC and this Note.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (g) Rights of
Investors.

     

    (i) Upon
the occurrence of an Event of Default, the Investors may require the Company to
assemble the Collateral and make it available to the Investors at the place to
be designated by the Investors which is reasonable convenient to both
parties.  The Investors may sell all or any part of the Collateral as
a whole or in parcels either by public auction, private sale, or other method of
disposition pursuant to UCC.  The Investors may bid at any public sale
on all or any portion of the public sale or of the Collateral.  The
Investors shall give the Company reasonable notice of the time and place of any
public sale or of the time after which any private sale or other disposition of
the Collateral is to be made, and notice given at least ten (10) days before the
time of the sale or other disposition shall be conclusively presumed to be
reasonable.

     

    (ii)
Notwithstanding any provision of this Note, the Investors shall be under no
obligation to offer to sell the Collateral.  In the event the
Investors offer to sell the Collateral, the Investors will be under no
obligation to consummate a sale of the Collateral if, in their reasonable
business judgment, none of the offers received by him reasonably approximates
the fair value of the Collateral.

     

    (iii) In
the event the Investors elect not to sell the Collateral, the Investors may
elect to follow the procedures set forth in the UCC for retaining the Collateral
in satisfaction of the Company’s obligation, subject to the Company’s rights
under such procedures.

     

    (h) Remedies
Cumulative.  Each remedy provided in this Note is distinct and
cumulative to all other rights or remedies under this Note or afforded by law or
equity, and may be exercised concurrently, independently, or successively, in
any order whatsoever.

     

    7. Conversion.

     

    (a) Automatic
Conversion.  In the event that the Company consummates, while
the Outstanding Debt is outstanding, an equity financing of not less than
$1,500,000, excluding any and all notes and other liabilities or indebtedness
which are converted, and with the principal purpose of raising capital (a “Qualified Equity Financing”),
then the Outstanding Debt shall automatically convert into the number of
securities issued as part of the Qualified Equity Financing equal to the
quotient of (x) the Outstanding Debt divided by (y) the Equity Financing
Conversion Price.  The securities shall otherwise be issued on the
same terms as such shares are issued to the lead investor that purchases the
securities in the Qualified Equity Financing.  Upon such conversion,
Investor hereby agrees to execute and deliver to the Company all transaction
documents related to the Qualified Equity Financing, including a purchase
agreement and other ancillary agreements having substantially the same terms
(other than price) as those agreements entered into by the other purchasers of
the securities, subject to Investor’s reasonable review and
approval.  Investor also agrees to deliver the original of this Note
(or a notice to the effect that the original Note has been lost, stolen or
destroyed along with an indemnity with respect thereto in a form satisfactory to
the Company) at the closing of the Qualified Equity Financing for cancellation;
provided, however, that
upon satisfaction of the conditions set forth in this Section 7(a), the
Outstanding Debt shall be deemed converted and the Company shall have no other
obligation to repay the Outstanding Debt, whether or not this Note is delivered
for cancellation as set forth in this sentence.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (b) Fractional Shares; Interest; Effect
of Conversion.  No fractional shares shall be issued upon
conversion of the Outstanding Debt.  In lieu of the Company issuing
any fractional shares to Investor upon the conversion of the Outstanding Debt,
the Company shall pay to Investor an amount equal to the product obtained by
multiplying the Equity Financing Conversion Price by the fraction of a share not
issued pursuant to the previous sentence.

     

    8. Successors and
Assigns.  Subject to the restrictions on transfer described in
Sections 10 and 12 below, the rights and obligations of the Company and Investor
shall be binding upon and benefit the successors, assigns, heirs, administrators
and transferees of the parties.

     

    9. Waiver and
Amendment.  Any provision of this Note may be amended, waived
or modified upon the written consent of the Company and the Investors holding
outstanding Notes. Any such amendment, waiver or modification effected in
accordance with this paragraph shall be binding upon the Company and the
Investors holding outstanding Notes.

     

    10. Transfer of this
Note or Securities Issuable on Conversion Hereof.  With respect
to any offer, sale or other disposition of this Note or securities into which
such Note may be converted, Investor will give written notice to the Company
prior thereto, describing briefly the manner thereof, together with a written
opinion of Investor’s counsel, or other evidence if reasonably satisfactory to
the Company, to the effect that such offer, sale or other distribution may be
effected without registration or qualification (under any federal or state law
then in effect, as applicable). Upon receiving such written notice and
reasonably satisfactory opinion, if so requested, or other evidence, the
Company, as promptly as practicable, shall notify Investor that Investor may
sell or otherwise dispose of this Note or such securities, all in accordance
with the terms of the notice delivered to the Company.  Each Note thus
transferred and each certificate representing the securities thus transferred
shall bear a legend as to the applicable restrictions on transferability in
order to ensure compliance with the Act, unless in the opinion of counsel for
the Company such legend is not required in order to ensure compliance with the
Securities Act.  The Company may issue stop transfer instructions to
its transfer agent in connection with such restrictions.  Subject to
the foregoing transfers of this Note shall be registered upon registration books
maintained for such purpose by or on behalf of the Company.  Prior to
presentation of this Note for registration of transfer, the Company shall treat
the registered holder hereof as the owner and holder of this Note for the
purpose of receiving all payments of principal and interest hereon and for all
other purposes whatsoever, whether or not this Note shall be overdue and the
Company shall not be affected by notice to the
contrary.  Notwithstanding the foregoing, the Investor may assign this
Note or securities into which such Note may be converted to an affiliated entity
without the prior written consent of the Company so long as such assignment
complies with applicable law.

     

    11. Representations
and Warranties.

     

    (a)
Investor represents and warrants to the Company that:

     

    (i) Authorization.  Investor
has full power and authority to enter into this Note. This Note constitutes a
valid and legally binding obligation of Investor, except as limited by
bankruptcy, insolvency or other laws of general application relating to or
affecting the enforcement of creditors’ rights generally and general principles
of equity.

     

    (ii)
Accredited
Investor.  Investor is an “accredited investor” within the
meaning of Rule 501 of Regulation D promulgated under the Securities
Act.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    (b) The
Company represents and warrants to Investor that:

     

    (i) Existence of
Company.  The Company is a duly organized Delaware
corporation.  The Company is validly existing and in good standing in
all jurisdictions where it conducts its business.

     

    (ii)
Authority to
Execute.  The execution, delivery and performance by the
Company of the  Notes and any financing statements hereunder are
within the Company’s corporate powers, have been duly authorized by all
necessary corporate action, do not and will not conflict with any provision of
law or organizational document of the Company (including its Articles of
Incorporation or Bylaws) or of any agreement or contractual restrictions binding
upon or affecting the Company or any of its property and need no further
stockholder or creditor consent.

     

    (iii)
No Stockholder Approval
Required.  No approval of the Company’s stockholders is
required for the issuance of the Notes, the granting of the security interest
hereunder or the issuance of any shares of stock upon conversion of the
Notes.

     

    (iv)
Binding
Obligation.  This Note is a legal, valid and binding obligation
of the Company enforceable against the Company in accordance with its respective
terms, subject, as to enforcement of remedies, to applicable bankruptcy,
insolvency, moratorium, reorganization and similar laws affecting creditors’
rights generally and to general equitable principles.

     

    (v) Litigation.  Except
as previously disclosed to Investor, no litigation or governmental proceeding is
pending or threatened against the Company which may have a materially adverse
effect on the financial condition,  operations or prospects of the
Company, and to the knowledge of the Company, no basis therefore
exists.

     

    (vi)
Intellectual
Property.  To the best of its knowledge, the Company owns or
possesses sufficient legal rights to all patents, trademarks, service marks,
trade names, copyrights, trade secrets, licenses, information and other
proprietary rights and processes necessary for its business as now conducted and
as presently proposed to be conducted, without any known infringement of the
rights of others.  There are no outstanding options, licenses or
agreements of any kind relating to the foregoing proprietary rights, nor is the
Company bound by or a party to any options, licenses or agreements of any kind
with respect to the patents, trademarks, service marks, trade names, copyrights,
trade secrets, licenses, information and other proprietary rights and processes
of any other person or entity other than such licenses or agreements arising
from the purchase of “off the shelf” or standard products.

     

    12. Assignment by the
Company.  Neither this Note nor any of the rights, interests or
obligations hereunder may be assigned, in whole or in part, (other than by
operation of law) by the Company without the prior written consent of the
Investors holding outstanding Notes.

     

    13. Notices.  All
notices, requests, demands, consents, instructions or other communications
required or permitted hereunder shall be in writing and faxed, mailed or
delivered to each party at the respective addresses of the parties as set forth
on the signature page hereto, or at such other address or facsimile number as a
party shall have furnished to the other party in writing.  All such
notices and communications will be deemed effectively given the earlier of
(i) when received, (ii) when delivered personally, (iii) one
business day after being delivered by facsimile (with receipt of appropriate
confirmation), (iv) one business day after being deposited with an
overnight courier service of recognized standing or (v) four days after
being deposited in the U.S. mail, first class with postage prepaid.

     

    14. Employees and
Agents.  The Investor may take any action hereunder by or
through agents or employees so long as such agents or employees are duly
authorized to so act on behalf of Investor.

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    15. Pari Passu
Notes.  Investor acknowledges and agrees that the payment of
all or any portion of the outstanding principal amount of this Note and all
interest hereon shall be pari
passu in right of payment and in all other respects to the other Note
issued on or around the date hereof.

     

    16. Relationship
between Noteholders.  For so long as both Notes are
outstanding, (i) Investor covenants to consult with and act in concert with the
registered holder of the other Note issued on or around the date hereof in
exercising any rights and remedies available to it under the UCC and Sections 5
and 6 of this Note and (ii) one Investor may act on behalf of both Investors
under the terms of this Note in the event the acting Investor has the written
consent of both Investors to so act.  In the event this Note remains
outstanding but the other Note issued on or around the date hereof is not
outstanding, (i) all rights and remedies of both Investors under this Note shall
remain applicable to the Investor and (ii) all action required under this Note
to be taken by both Investors may be taken solely by the Investor.

     

    17. Payment.  Payment
shall be made in lawful tender of the United States.

     

    18. Expenses;
Waivers.  If this Note is not paid when due and Investor takes
any action to enforce Investor’s rights hereunder, the Company shall promptly
pay upon demand by Investor all such reasonable costs of collection, including
reasonable attorneys’ fees, whether or not litigation is
commenced.  The Company hereby waives notice of default, presentment
or demand for payment, protest or notice of nonpayment or dishonor and all other
notices or demands relative to this instrument.  The Company also
shall pay for all attorney’s fees incurred by the Investor related to the
drafting and preparation of this Note.

     

    19. Governing
Law.  This Note and all actions arising out of or in connection
with this Note shall be governed by and construed in accordance with the laws of
the State of California, without regard to the conflicts of law provisions of
the State of California, or of any other state.

     

    20. Effectiveness.  This
Note shall become effective upon the execution of both Notes by the Company and
both Investors.

     

     

    [Remainder
of Page Intentionally Left Blank]

     

    
      
        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

     

    The Company has caused this Note to be
issued as of the date first written above and agrees to all the terms set forth
above.

     

    
      	 	CNS RESPONSE,
      INC.	 
	 	 	 	 
	 	
              By:
      

            	/s/ Leonard
      Brandt	 
	 	Name:
      Leonard Brandt	 
	 	Title:
      CEO	 
	 	 	 	 

       

      
        
          	

                  Accepted
      and agreed:

                   

                  INVESTOR: SAIL
      VENTURE PARTNERS, LP

                	 
	 	 	 
	
                  By:
      

                	/s/ David
      Jones	 
	Name:
      	David
      B. Jones	 
	Title:
      	Managing
      Partner	 
	 	 	 
	 	 

        

      

    

     

    
      	
              Address: 

            	
               600
      Anton Blvd., Suite 1010

            

    

    Costa
Mesa, CA 92626v144393_ex10-13 -- Converted by SECPublisher 2.1.1.8, created by BCL Technologies Inc., for SEC Filing

    Exhibit
10.13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00157-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00157-of-00352.parquet"}]]